Janus Henderson Group
EPIX

Janus Henderson Group’s ESSA Pharma EPIX Stock Holding History

Janus Henderson Group’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,006,202
Closed -$5.19M – 2538
2024
Q2 		$5.19M Sell
1,006,202
-169,040
-14% -$1.07M ﹤0.01% 833
2024
Q1 		$9.98M Buy
1,175,242
+85,760
+8% +$749K 0.01% 693
2023
Q4 		$7.13M Buy
+1,089,482
New +$5.37M ﹤0.01% 727
2022
Q3 		– Sell
-2,909,410
Closed -$9.17M – 2302
2022
Q2 		$9.17M Sell
2,909,410
-563,390
-16% -$3.15M 0.01% 713
2022
Q1 		$21.5M Buy
3,472,800
+68,093
+2% +$599K 0.01% 731
2021
Q4 		$48.3M Sell
3,404,707
-73,137
-2% -$815K 0.02% 557
2021
Q3 		$27.8M Buy
3,477,844
+1,459,950
+72% +$23.2M 0.01% 710
2021
Q2 		$57.7M Buy
2,017,894
+501,792
+33% +$14.6M 0.02% 532
2021
Q1 		$44M Buy
1,516,102
+1,007,007
+198% +$23.4M 0.02% 585
2020
Q4 		$6M Buy
509,095
+33,407
+7% +$235K ﹤0.01% 931
2020
Q3 		$3.26M Buy
475,688
+74,092
+18% +$503K ﹤0.01% 981
2020
Q2 		$2.46M Buy
401,596
+202,797
+102% +$962K ﹤0.01% 1004
2020
Q1 		$796K Buy
+198,799
New +$1M ﹤0.01% 1129

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Janus Henderson Group's EPIX Position: Q3 2024 in Review

Janus Henderson Group sold out of ESSA Pharma (EPIX) in Q3 2024, closing a stake of 1,006,202 shares — an estimated $5.19M sold.

Janus Henderson Group first reported a position in EPIX in Q1 2020 and held it in 13 quarters. The position peaked at $57.7M in Q2 2021. 32 funds tracked by Wall St. Rank hold EPIX as of Q3 2024.

  • Janus Henderson Group reported no remaining ESSA Pharma position as of Q3 2024 after selling out during the quarter.
  • Janus Henderson Group sold 1,006,202 ESSA Pharma shares in Q3 2024, an estimated $5.19M.
  • Janus Henderson Group first reported a position in ESSA Pharma in Q1 2020 and held it in 13 quarters.
  • Janus Henderson Group's ESSA Pharma position peaked at $57.7M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2024.

Based on Janus Henderson Group's 13F filing for Q3 2024, filed 14 Nov 2024.